PPARα siRNA–Treated Expression Profiles Uncover the Causal Sufficiency Network for Compound-Induced Liver Hypertrophy

• Xudong Dai ,

  *To whom correspondence should be addressed. E-mail: xudong_dai@merck.com (XD); yudong_he@merck.com (YDH)

  Affiliation Informatics, Rosetta Inpharmatics, Seattle, Washington, United States of America

  ⨯
• Angus T. De Souza,

  Affiliation Preclinical Molecular Profiling, Rosetta Inpharmatics, Seattle, Washington, United States of America

  ⨯
• Hongyue Dai,

  Affiliation Informatics, Rosetta Inpharmatics, Seattle, Washington, United States of America

  ⨯
• David L Lewis,

  Affiliation Mirus Bio Corporation, Madison, Wisconsin, United States of America

  ⨯
• Chang-kyu Lee,

  Affiliation Informatics, Rosetta Inpharmatics, Seattle, Washington, United States of America

  ⨯
• Andy G Spencer,

  Affiliation Mirus Bio Corporation, Madison, Wisconsin, United States of America

  ⨯
• Hans Herweijer,

  Affiliation Mirus Bio Corporation, Madison, Wisconsin, United States of America

  ⨯
• Jim E Hagstrom,

  Affiliation Mirus Bio Corporation, Madison, Wisconsin, United States of America

  ⨯
• Peter S Linsley,

  Affiliation Cancer Biology, Rosetta Inpharmatics, Seattle, Washington, United States of America

  ⨯
• Douglas E Bassett,

  Affiliation Informatics, Rosetta Inpharmatics, Seattle, Washington, United States of America

  ⨯
• Roger G Ulrich,

  Affiliation Preclinical Molecular Profiling, Rosetta Inpharmatics, Seattle, Washington, United States of America

  ⨯
• Yudong D He

  *To whom correspondence should be addressed. E-mail: xudong_dai@merck.com (XD); yudong_he@merck.com (YDH)

  Affiliation Informatics, Rosetta Inpharmatics, Seattle, Washington, United States of America

  ⨯